{"PubmedArticle": [{"MedlineCitation": {"KeywordList": [["Molecular docking", "Moroccan plants", "SARS-CoV2", "anti-COVID 19"]], "GeneralNote": [], "OtherAbstract": [], "CitationSubset": [], "SpaceFlightMission": [], "OtherID": [], "InvestigatorList": [], "PMID": "33888980", "DateRevised": {"Year": "2024", "Month": "05", "Day": "04"}, "Article": {"ArticleDate": [{"Year": "2021", "Month": "04", "Day": "08"}], "Language": ["eng"], "ELocationID": ["11779322211009199", "10.1177/11779322211009199"], "Journal": {"ISSN": "1177-9322", "JournalIssue": {"Volume": "15", "PubDate": {"Year": "2021"}}, "Title": "Bioinformatics and biology insights", "ISOAbbreviation": "Bioinform Biol Insights"}, "ArticleTitle": "Prediction of Anti-COVID 19 Therapeutic Power of Medicinal Moroccan Plants Using Molecular Docking.", "Pagination": {"StartPage": "11779322211009199", "MedlinePgn": "11779322211009199"}, "Abstract": {"AbstractText": ["The emerging pathogen SARS-CoV2 causing coronavirus disease 2019 (COVID-19) is a global public health challenge. To the present day, COVID-19 had affected more than 40 million people worldwide. The exploration and the development of new bioactive compounds with cost-effective and specific anti-COVID 19 therapeutic power is the prime focus of the current medical research. Thus, the exploitation of the molecular docking technique has become essential in the discovery and development of new drugs, to better understand drug-target interactions in their original environment. This work consists of studying the binding affinity and the type of interactions, through molecular docking, between 54 compounds from Moroccan medicinal plants, dextran sulfate and heparin (compounds not derived from medicinal plants), and 3CLpro-SARS-CoV-2, ACE2, and the post fusion core of 2019-nCoV S2 subunit. The PDB files of the target proteins and prepared herbal compounds (ligands) were subjected for docking to AutoDock Vina using UCSF Chimera, which provides a list of potential complexes based on the criteria of form complementarity of the natural compound with their binding affinities. The results of molecular docking revealed that Taxol, Rutin, Genkwanine, and Luteolin-glucoside have a high affinity with ACE2 and 3CLpro. Therefore, these natural compounds can have 2 effects at once, inhibiting 3CLpro and preventing recognition between the virus and ACE2. These compounds may have a potential therapeutic effect against SARS-CoV2, and therefore natural anti-COVID-19 compounds."], "CopyrightInformation": "\u00a9 The Author(s) 2021."}, "AuthorList": [{"Identifier": ["0000-0001-5175-4601"], "AffiliationInfo": [{"Identifier": [], "Affiliation": "Laboratory of Health and Environment, Faculty of Sciences A\u00efn Chock, Hassan II University of Casablanca, Casablanca, Morocco."}], "LastName": "Nouadi", "ForeName": "Badreddine", "Initials": "B"}, {"Identifier": [], "AffiliationInfo": [{"Identifier": [], "Affiliation": "Laboratory of Health and Environment, Faculty of Sciences A\u00efn Chock, Hassan II University of Casablanca, Casablanca, Morocco."}], "LastName": "Ezaouine", "ForeName": "Abdelkarim", "Initials": "A"}, {"Identifier": [], "AffiliationInfo": [{"Identifier": [], "Affiliation": "Laboratory of Health and Environment, Faculty of Sciences A\u00efn Chock, Hassan II University of Casablanca, Casablanca, Morocco."}], "LastName": "El Messal", "ForeName": "Mariame", "Initials": "M"}, {"Identifier": [], "AffiliationInfo": [{"Identifier": [], "Affiliation": "Laboratory of Plant Biotechnology, Ecology and Ecosystem Valorization, Faculty of Sciences El Jadida, Choua\u00efb Doukkali University, El Jadida, Morocco."}], "LastName": "Blaghen", "ForeName": "Mohamed", "Initials": "M"}, {"Identifier": [], "AffiliationInfo": [{"Identifier": [], "Affiliation": "Laboratory of Health and Environment, Faculty of Sciences A\u00efn Chock, Hassan II University of Casablanca, Casablanca, Morocco."}], "LastName": "Bennis", "ForeName": "Faiza", "Initials": "F"}, {"Identifier": [], "AffiliationInfo": [{"Identifier": [], "Affiliation": "Laboratory of Health and Environment, Faculty of Sciences A\u00efn Chock, Hassan II University of Casablanca, Casablanca, Morocco."}], "LastName": "Chegdani", "ForeName": "Fatima", "Initials": "F"}], "GrantList": [{"GrantID": "P41 GM103311", "Acronym": "GM", "Agency": "NIGMS NIH HHS", "Country": "United States"}], "PublicationTypeList": ["Journal Article"]}, "MedlineJournalInfo": {"Country": "United States", "MedlineTA": "Bioinform Biol Insights", "NlmUniqueID": "101467187", "ISSNLinking": "1177-9322"}, "CoiStatement": "Declaration of Conflicting Interests:The author(s) declared no potential conflicts of interest with respect to the research, authorship, and/or publication of this article."}, "PubmedData": {"ReferenceList": [{"Reference": [{"Citation": "Gao GF. From \u2018A\u2019IV to \u2018Z\u2019IKV: attacks from emerging and re-emerging pathogens. Cell. 2018;172:1157-1159. doi:10.1016/j.cell.2018.02.025.", "ArticleIdList": ["10.1016/j.cell.2018.02.025.", "PMC7126677", "29522735"]}, {"Citation": "Peiris JSM. Coronaviruses. In: Richman DD, Whitley RJ, Hayden FG, eds. Clinical Virology. New York, NY: John Wiley & Sons, Ltd; 2016:1243-1265. doi:10.1128/9781555819439.ch52.", "ArticleIdList": ["10.1128/9781555819439.ch52."]}, {"Citation": "Zhu N, Zhang D, Wang W, et al.. A novel coronavirus from patients with pneumonia in China, 2019. N Engl J Med. 2020;382:727-733. doi:10.1056/NEJMoa2001017.", "ArticleIdList": ["10.1056/NEJMoa2001017.", "PMC7092803", "31978945"]}, {"Citation": "Holshue ML, DeBolt C, Lindquist S, et al.. First case of 2019 novel coronavirus in the United States. N Engl J Med. 2020;382:929-936. doi:10.1056/NEJMoa2001191.", "ArticleIdList": ["10.1056/NEJMoa2001191.", "PMC7092802", "32004427"]}, {"Citation": "Rothe C, Schunk M, Sothmann P, et al.. Transmission of 2019-nCoV infection from an asymptomatic contact in Germany. N Engl J Med. 2020;382:970-971. doi:10.1056/NEJMc2001468.", "ArticleIdList": ["10.1056/NEJMc2001468.", "PMC7120970", "32003551"]}, {"Citation": "Young BE, Ong SWX, Kalimuddin S, et al.. Epidemiologic features and clinical course of patients infected with SARS-CoV-2 in Singapore. JAMA. 2020;323:1488-1494. doi:10.1001/jama.2020.3204.", "ArticleIdList": ["10.1001/jama.2020.3204.", "PMC7054855", "32125362"]}, {"Citation": "Guan W, Ni Z, Hu Y, et al.. Clinical characteristics of coronavirus disease 2019 in China. N Engl J Med. 2020;328:1708-1720. doi:10.1056/NEJMoa2002032.", "ArticleIdList": ["10.1056/NEJMoa2002032.", "PMC7092819", "32109013"]}, {"Citation": "Li Q, Guan X, Wu P, et al.. Early transmission dynamics in Wuhan, China, of novel coronavirus\u2013infected pneumonia. N Engl J Med. 2020;382:1199-1207. doi:10.1056/NEJMoa2001316.", "ArticleIdList": ["10.1056/NEJMoa2001316.", "PMC7121484", "31995857"]}, {"Citation": "Wang D, Hu B, Hu C, et al.. Clinical characteristics of 138 hospitalized patients with 2019 novel coronavirus\u2013infected pneumonia in Wuhan, China. JAMA. 2020;323:1061-1069. doi:10.1001/jama.2020.1585.", "ArticleIdList": ["10.1001/jama.2020.1585.", "PMC7042881", "32031570"]}, {"Citation": "Huang C, Wang Y, Li X, et al.. Clinical features of patients infected with 2019 novel coronavirus in Wuhan, China. Lancet. 2020;395:497-506. doi:10.1016/S0140-6736(20)30183-5.", "ArticleIdList": ["10.1016/S0140-6736(20)30183-5.", "PMC7159299", "31986264"]}, {"Citation": "Chen N, Zhou M, Dong X, et al.. Epidemiological and clinical characteristics of 99 cases of 2019 novel coronavirus pneumonia in Wuhan, China: a descriptive study. Lancet. 2020;395:507-513. doi:10.1016/S0140-6736(20)30211-7.", "ArticleIdList": ["10.1016/S0140-6736(20)30211-7.", "PMC7135076", "32007143"]}, {"Citation": "\nWHO coronavirus disease (COVID-19) dashboard. https://covid19.who.int. Accessed October 20, 2020."}, {"Citation": "Wu R, Wang L, Kuo H-CD, et al.. An update on current therapeutic drugs treating COVID-19 [published online ahead of print May 11, 2020]. Curr Pharmacol Rep. doi:10.1007/s40495-020-00216-7.", "ArticleIdList": ["10.1007/s40495-020-00216-7.", "PMC7211915", "32395418"]}, {"Citation": "Ahmadi A, Zorofchian Moghadamtousi S, Abubakar S, Zandi K. Antiviral potential of algae polysaccharides isolated from marine sources: a review. Biomed Res Int. 2015;2015:825203. doi:10.1155/2015/825203.", "ArticleIdList": ["10.1155/2015/825203.", "PMC4592888", "26484353"]}, {"Citation": "Ogbole OO, Akinleye TE, Segun PA, Faleye TC, Adeniji AJ. In vitro antiviral activity of twenty-seven medicinal plant extracts from Southwest Nigeria against three serotypes of echoviruses. Virol J. 2018;15:110. doi:10.1186/s12985-018-1022-7.", "ArticleIdList": ["10.1186/s12985-018-1022-7.", "PMC6052623", "30021589"]}, {"Citation": "Mahmoud Jarrar YB, Alshaer W, Ismail S. SARS-CoV-2 entry in host cells-multiple targets for treatment and prevention. Biochimie. 2020;175:93-98. doi:10.1016/j.biochi.2020.05.012.", "ArticleIdList": ["10.1016/j.biochi.2020.05.012.", "PMC7258854", "32479856"]}, {"Citation": "Gelman R, Bayatra A, Kessler A, Schwartz A, Ilan Y. Targeting SARS-CoV-2 receptors as a means for reducing infectivity and improving antiviral and immune response: an algorithm-based method for overcoming resistance to antiviral agents. Emerg Microbes Infect. 2020;9:1397-1406. doi:10.1080/22221751.2020.1776161.", "ArticleIdList": ["10.1080/22221751.2020.1776161.", "PMC7473106", "32490731"]}, {"Citation": "Jamshaid H, Zahid F, ud Din I, et al.. Diagnostic and treatment strategies for COVID-19. AAPS Pharmscitech. 2020;21:222. doi:10.1208/s12249-020-01756-3.", "ArticleIdList": ["10.1208/s12249-020-01756-3.", "PMC7398284", "32748244"]}, {"Citation": "Rehman M, Tauseef I, Aalia B, Shah SH, Junaid M, Haleem KS. Therapeutic and vaccine strategies against SARS-CoV-2: past, present and future. Future Virol. 2020;15:471-482. doi:10.2217/fvl-2020-0137.", "ArticleIdList": ["10.2217/fvl-2020-0137."]}, {"Citation": "Kitchen DB, Decornez H, Furr JR, Bajorath J. Docking and scoring in virtual screening for drug discovery: methods and applications. Nat Rev Drug Discov. 2004;3:935-949. doi:10.1038/nrd1549.", "ArticleIdList": ["10.1038/nrd1549.", "15520816"]}, {"Citation": "Fan J, Fu A, Zhang L. Progress in molecular docking. Quant Biol. 2019;7:83-89. doi:10.1007/s40484-019-0172-y.", "ArticleIdList": ["10.1007/s40484-019-0172-y."]}, {"Citation": "Berman HM, Westbrook J, Feng Z, et al.. The protein data bank. Nucleic Acids Res. 2000;28:235-242.", "ArticleIdList": ["PMC102472", "10592235"]}, {"Citation": "Wishart DS, Knox C, Guo AC, et al.. DrugBank: a comprehensive resource for in silico drug discovery and exploration. Nucleic Acids Res. 2006;34:D668-D672. doi:10.1093/nar/gkj067.", "ArticleIdList": ["10.1093/nar/gkj067.", "PMC1347430", "16381955"]}, {"Citation": "Bento AP, Gaulton A, Hersey A, et al.. The ChEMBL bioactivity database: an update. Nucleic Acids Res. 2014;42:D1083-D1090. doi:10.1093/nar/gkt1031.", "ArticleIdList": ["10.1093/nar/gkt1031.", "PMC3965067", "24214965"]}, {"Citation": "Irwin JJ, Shoichet BK. ZINC \u2013 a free database of commercially available compounds for virtual screening. J Chem Inf Model. 2005;45:177-182. doi:10.1021/ci049714.", "ArticleIdList": ["10.1021/ci049714.", "PMC1360656", "15667143"]}, {"Citation": "Kim S, Thiessen PA, Bolton EE, et al.. PubChem substance and compound databases. Nucleic Acids Res. 2016;44:D1202-D1213. doi:10.1093/nar/gkv951.", "ArticleIdList": ["10.1093/nar/gkv951.", "PMC4702940", "26400175"]}, {"Citation": "Fang Y. Combining label-free cell phenotypic profiling with computational approaches for novel drug discovery. Expert Opin Drug Discov. 2015;10:331-343. doi:10.1517/17460441.2015.1020788.", "ArticleIdList": ["10.1517/17460441.2015.1020788.", "25727255"]}, {"Citation": "\nAdiguzel A, Ozer H, Kilic H, Cetin B. Screening of antimicrobial activity of essential oil and methanol extract of Satureja hortensis on foodborne bacteria and fungi. Czech J Food Sci. 2007;25:81-89. https://agris.fao.org/agris-search/search.do?recordID=CZ2007000420. Accessed October 28, 2020."}, {"Citation": "\u010cetojevi\u0107-Simin DD, Veli\u0107anski AS, Cvetkovi\u0107 DD, et al.. Bioactivity of lemon balm Kombucha. Food Bioprocess Technol. 2012;5:1756-1765. doi:10.1007/s11947-010-0458-6.", "ArticleIdList": ["10.1007/s11947-010-0458-6."]}, {"Citation": "Nebia B, Khalladi Mederbal DB. Chemical composition of the essential oil of Satureja calamintha subsp. Nepeta of west Algerian. Moroc J Chem. 2018;6:213-217."}, {"Citation": "Andre CM, Hausman J-F, Guerriero G. Cannabis sativa: the plant of the thousand and one molecules. Front Plant Sci. 2016;7:19. doi:10.3389/fpls.2016.00019.", "ArticleIdList": ["10.3389/fpls.2016.00019.", "PMC4740396", "26870049"]}, {"Citation": "Talbaoui A, Hamdaoui L, Bouyahya A, El Moussaouiti M, Bakri Y. Chemical composition, in vitro cytotoxic, and antibacterial activities of Moroccan medicinal plants Euphorbia resinifera and Marrubium vulgare. Biointerface Res Appl Chem. 2020;10:7343-7355. doi:10.33263/BRIAC106.73437355.", "ArticleIdList": ["10.33263/BRIAC106.73437355."]}, {"Citation": "Zrira S. Some important aromatic and medicinal plants of Morocco. In: Neffati M, Najjaa H, M\u00e1th\u00e9 \u00c1, eds. Medicinal and aromatic plants of the world \u2013 Africa Volume 3. Medicinal and aromatic plants of the world. Dordrecht, The Netherlands: Springer; 2017:91-125. doi:10.1007/978-94-024-1120-1_5.", "ArticleIdList": ["10.1007/978-94-024-1120-1_5."]}, {"Citation": "Nakashima H, Yoshida O, Baba M, De Clercq E, Yamamoto N. Anti-HIV activity of dextran sulphate as determined under different experimental conditions. Antiviral Res. 1989;11:233-246. doi:10.1016/0166-3542(89)90033-8.", "ArticleIdList": ["10.1016/0166-3542(89)90033-8.", "2478075"]}, {"Citation": "Conzelmann C, M\u00fcller JA, Perkhofer L, et al.. \u201cInhaled and systemic heparin as a repurposed direct antiviral drug for prevention and treatment of COVID-19.\u201d Clin Med. 2020;20(6):e218\u2013e221. doi: 10.7861/clinmed.2020-0351.", "ArticleIdList": ["PMC7687307", "32863274"]}, {"Citation": "Pettersen EF, Goddard TD, Huang CC, et al.. UCSF chimera \u2013 a visualization system for exploratory research and analysis. J Comput Chem. 2004;25:1605-1612. doi:10.1002/jcc.20084.", "ArticleIdList": ["10.1002/jcc.20084.", "15264254"]}, {"Citation": "Trott O, Olson AJ. AutoDock Vina: improving the speed and accuracy of docking with a new scoring function, efficient optimization and multithreading. J Comput Chem. 2010;31:455-461. doi:10.1002/jcc.21334.", "ArticleIdList": ["10.1002/jcc.21334.", "PMC3041641", "19499576"]}, {"Citation": "BIOVIA. Dassault Syst\u00e8mes. Discovery Studio Modeling Environment. San Diego, CA: Dassault Syst\u00e8mes; 2020."}, {"Citation": "Newton J, Allen A, Westley B, May F. The human trefoil peptide, TFF1, is present in different molecular forms that are intimately associated with mucus in normal stomach. Gut. 2000;46:312-320. doi:10.1136/gut.46.3.312.", "ArticleIdList": ["10.1136/gut.46.3.312.", "PMC1727855", "10673290"]}, {"Citation": "Vuille-dit-Bille RN, Camargo SM, Emmenegger L, et al.. Human intestine luminal ACE2 and amino acid transporter expression increased by ACE-inhibitors. Amino Acids. 2015;47:693-705. doi:10.1007/s00726-014-1889-6.", "ArticleIdList": ["10.1007/s00726-014-1889-6.", "25534429"]}, {"Citation": "Kwon PS, Oh H, Kwon S-J, et al.. Sulfated polysaccharides effectively inhibit SARS-CoV-2 in vitro. Cell Discov. 2020;6:50-54. doi:10.1038/s41421-020-00192-8.", "ArticleIdList": ["10.1038/s41421-020-00192-8.", "PMC7378085", "32714563"]}, {"Citation": "Chen L-R, Wang Y-C, Lin YW, et al.. Synthesis and evaluation of isatin derivatives as effective SARS coronavirus 3CL protease inhibitors. Bioorg Med Chem Lett. 2005;15:3058-3062. doi:10.1016/j.bmcl.2005.04.027.", "ArticleIdList": ["10.1016/j.bmcl.2005.04.027.", "PMC7119080", "15896959"]}, {"Citation": "Huang C, Wei P, Fan K, Liu Y, Lai L. 3C-like proteinase from SARS coronavirus catalyzes substrate hydrolysis by a general base mechanism. Biochemistry. 2004;43:4568-4574. doi:10.1021/bi036022q.", "ArticleIdList": ["10.1021/bi036022q.", "15078103"]}, {"Citation": "Bartlam M, Yang H, Rao Z. Structural insights into SARS coronavirus proteins. Curr Opin Struct Biol. 2005;15:664-672. doi:10.1016/j.sbi.2005.10.004.", "ArticleIdList": ["10.1016/j.sbi.2005.10.004.", "PMC7127763", "16263266"]}, {"Citation": "Chou K-C, Wei D-Q, Zhong W-Z. Binding mechanism of coronavirus main proteinase with ligands and its implication to drug design against SARS. Biochem Biophys Res Commun. 2003;308:148-151. doi:10.1016/S0006-291X(03)01342-1.", "ArticleIdList": ["10.1016/S0006-291X(03)01342-1.", "PMC7111004", "12890493"]}, {"Citation": "Ghosh AK, Xi K, Grum-Tokars V, et al.. Structure-based design, synthesis, and biological evaluation of peptidomimetic SARS-CoV 3CLpro inhibitors. Bioorg Med Chem Lett. 2007;17:5876-5880. doi:10.1016/j.bmcl.2007.08.031.", "ArticleIdList": ["10.1016/j.bmcl.2007.08.031.", "PMC2112940", "17855091"]}, {"Citation": "Jin Z, Du X, Xu Y, et al.. Structure of Mpro from SARS-CoV-2 and discovery of its inhibitors. Nature. 2020;582:289-293. doi:10.1038/s41586-020-2223-y.", "ArticleIdList": ["10.1038/s41586-020-2223-y.", "32272481"]}, {"Citation": "Wu C, Liu Y, Yang Y, et al.. Analysis of therapeutic targets for SARS-CoV-2 and discovery of potential drugs by computational methods. Acta Pharm Sin B. 2020;10:766-788. doi:10.1016/j.apsb.2020.02.008.", "ArticleIdList": ["10.1016/j.apsb.2020.02.008.", "PMC7102550", "32292689"]}, {"Citation": "Stebbing J, Wildfire A, Portsmouth S, et al.. Paclitaxel for anthracycline-resistant AIDS-related Kaposi\u2019s sarcoma: clinical and angiogenic correlations. Ann Oncol. 2003;14:1660-1666. doi:10.1093/annonc/mdg461.", "ArticleIdList": ["10.1093/annonc/mdg461.", "14581275"]}, {"Citation": "Krawczyk E, Luczak M, Majewska A. [Antiviral and cytotoxic activities of new derivatives of natural sesquiterpenes and taxol]. Med Dosw Mikrobiol. 2005;57:93-99.", "ArticleIdList": ["16130299"]}, {"Citation": "Ryang J, Yan Y, Song Y, Liu F, Ng TB. Anti-HIV, antitumor and immunomodulatory activities of paclitaxel from fermentation broth using molecular imprinting technique. AMB Express. 2019;9:194. doi:10.1186/s13568-019-0915-1.", "ArticleIdList": ["10.1186/s13568-019-0915-1.", "PMC6890922", "31797089"]}, {"Citation": "Carvalho OV, Botelho CV, Ferreira CGT, et al.. In vitro inhibition of canine distemper virus by flavonoids and phenolic acids: implications of structural differences for antiviral design. Res Vet Sci. 2013;95:717-724. doi:10.1016/j.rvsc.2013.04.013.", "ArticleIdList": ["10.1016/j.rvsc.2013.04.013.", "23664014"]}, {"Citation": "da Cruz RC, Agertt V, Boligon AA, et al.. In vitro antimycobacterial activity and HPLC-DAD screening of phenolics from Ficus benjamina L. and Ficus luschnathiana (Miq.) Miq. leaves. Nat Prod Res. 2012;26:2251-2254. doi:10.1080/14786419.2011.650637.", "ArticleIdList": ["10.1080/14786419.2011.650637.", "22235967"]}, {"Citation": "Ibrahim AK, Youssef AI, Arafa AS, Ahmed SA. Anti-H5N1 virus flavonoids from Capparis sinaica Veill. Nat Prod Res. 2013;27:2149-2153. doi:10.1080/14786419.2013.790027.", "ArticleIdList": ["10.1080/14786419.2013.790027.", "23651316"]}, {"Citation": "Hakobyan A, Arabyan E, Kotsinyan A, et al.. Inhibition of African swine fever virus infection by genkwanin. Antiviral Res. 2019;167:78-82. doi:10.1016/j.antiviral.2019.04.008.", "ArticleIdList": ["10.1016/j.antiviral.2019.04.008.", "30991087"]}, {"Citation": "Ding Y, Cao Z, Cao L, Ding G, Wang Z, Xiao W. Antiviral activity of chlorogenic acid against influenza A (H1N1/H3N2) virus and its inhibition of neuraminidase. Sci Rep. 2017;7:45723. doi:10.1038/srep45723.", "ArticleIdList": ["10.1038/srep45723.", "PMC5385491", "28393840"]}], "ReferenceList": []}], "History": [{"Year": "2020", "Month": "12", "Day": "12"}, {"Year": "2021", "Month": "3", "Day": "21"}, {"Year": "2021", "Month": "4", "Day": "23", "Hour": "6", "Minute": "22"}, {"Year": "2021", "Month": "4", "Day": "24", "Hour": "6", "Minute": "0"}, {"Year": "2021", "Month": "4", "Day": "24", "Hour": "6", "Minute": "1"}, {"Year": "2021", "Month": "4", "Day": "8"}], "PublicationStatus": "epublish", "ArticleIdList": ["33888980", "PMC8040561", "10.1177/11779322211009199", "10.1177_11779322211009199"]}}], "PubmedBookArticle": []}